Medtronic PLC Valuation
| 2M6 Stock | 86.88 0.86 1.00% |
At this time, the firm appears to be overvalued. Medtronic PLC secures a last-minute Real Value of USD69.5 per share. The latest price of the firm is USD86.88. Our model forecasts the value of Medtronic PLC from analyzing the firm fundamentals such as Return On Equity of 0.0833, current valuation of 113.84 B, and Profit Margin of 0.14 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Medtronic PLC's price fluctuation is very steady at this time. Calculation of the real value of Medtronic PLC is based on 3 months time horizon. Increasing Medtronic PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Medtronic PLC's intrinsic value may or may not be the same as its current market price of 86.88, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 86.88 | Real 69.5 | Hype 86.88 | Naive 86.76 |
The intrinsic value of Medtronic PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medtronic PLC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medtronic PLC helps investors to forecast how Medtronic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medtronic PLC more accurately as focusing exclusively on Medtronic PLC's fundamentals will not take into account other important factors: Medtronic PLC Total Value Analysis
Medtronic PLC is presently forecasted to have takeover price of 113.84 B with market capitalization of 102.34 B, debt of 20.37 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medtronic PLC fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
113.84 B | 102.34 B | 20.37 B |
Medtronic PLC Investor Information
About 85.0% of the company shares are owned by institutions such as pension funds. The book value of Medtronic PLC was presently reported as 39.0. The company last dividend was issued on the 20th of December 2022. Based on the measurements of operating efficiency obtained from Medtronic PLC's historical financial statements, Medtronic PLC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Medtronic PLC Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medtronic PLC has an asset utilization ratio of 34.83 percent. This implies that the Company is making USD0.35 for each dollar of assets. An increasing asset utilization means that Medtronic PLC is more efficient with each dollar of assets it utilizes for everyday operations.Medtronic PLC Ownership Allocation
Medtronic PLC maintains a total of 1.33 Billion outstanding shares. The majority of Medtronic PLC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Medtronic PLC to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Medtronic PLC. Please pay attention to any change in the institutional holdings of Medtronic PLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medtronic PLC Profitability Analysis
The company reported the revenue of 31.69 B. Net Income was 5.04 B with profit before overhead, payroll, taxes, and interest of 21.71 B.About Medtronic PLC Valuation
The stock valuation mechanism determines Medtronic PLC's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Medtronic PLC based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medtronic PLC. We calculate exposure to Medtronic PLC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medtronic PLC's related companies.8 Steps to conduct Medtronic PLC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medtronic PLC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medtronic PLC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medtronic PLC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medtronic PLC's revenue streams: Identify Medtronic PLC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medtronic PLC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medtronic PLC's growth potential: Evaluate Medtronic PLC's management, business model, and growth potential.
- Determine Medtronic PLC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medtronic PLC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.